Jörg Trojan
ORCID：0000-0003-4110-2647
发表论文 167 篇 · 总被引 10815 次 · h-index 40
代表论文
- Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial (2022 · Journal of Clinical Oncology · 被引 136)
- Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies (2023 · Hepatology Communications · 被引 56)
- Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis (2022 · JGH Open · 被引 25)
- Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies (2024 · JHEP Reports · 被引 19)
- Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis (2022 · Cancers · 被引 13)
- Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial (2024 · Annals of Surgical Oncology · 被引 11)